Your browser doesn't support javascript.
loading
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider.
Garcia-Revilla, Juan; Deierborg, Tomas; Venero, Jose Luis; Boza-Serrano, Antonio.
Affiliation
  • Garcia-Revilla J; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Deierborg T; Department of Experimental Medical Science, Experimental Neuroinflammation Laboratory, BMC, Lund University, Lund, Sweden.
  • Venero JL; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Boza-Serrano A; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
Front Immunol ; 11: 2069, 2020.
Article in En | MEDLINE | ID: mdl-32973815

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Pulmonary Fibrosis / Severity of Illness Index / Coronavirus Infections / Galectin 3 / Molecular Targeted Therapy / Betacoronavirus Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: Spain Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Pulmonary Fibrosis / Severity of Illness Index / Coronavirus Infections / Galectin 3 / Molecular Targeted Therapy / Betacoronavirus Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: Spain Country of publication: Switzerland